Skip to main content
Premium Trial:

Request an Annual Quote

Lynx Therapeutics in Services Agreement with National Institute of Aging

NEW YORK, May 7 - Lynx Therapeutics of Hayward, Calif., today announced that it has entered a service agreement with the National Institute on Aging of the NIH to study stem cell gene expression using its MPSS technology.

 

Lynx will receive payments for the services it performs on samples provided by the NIA under this agreement. Further details were not provided.

 

The company said that an analysis of human astrocyte precursor cells undertaken for Cue Therapeutics helped propel the NIA to initiate analysis of additional human stem cells using Lynx's massively parallel signature sequencing technology.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.